JoinClinicalTrials.com

• Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy

  NCT01586767

  Conditions:   Adenoid Cystic Carcinoma;   Squamous Cell Carcinoma;   Sinonasal Carcinoma;   Sinonasal Undifferentiated Carcinoma;   Mucoepidermoid Carcinoma;   Schneiderian Carcinoma;   Myoepithelial Carcinoma;   Esthesioneuroblastoma;   Melanoma
  Interventions:   Radiation: Proton radiation therapy;   Radiation: Intensity-modulated radiotherapy
  Sponsors:   Massachusetts General Hospital;   National Institutes of Health (NIH);   National Cancer Institute (NCI)
  Recruiting
• Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  NCT01473784

  Conditions:   Recurrent Adenoid Cystic Carcinoma of the Oral Cavity;   Recurrent Mucoepidermoid Carcinoma of the Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Stage 0 Hypopharyngeal Cancer;   Stage 0 Laryngeal Cancer;   Stage 0 Lip and Oral Cavity Cancer;   Stage I Adenoid Cystic Carcinoma of the Oral Cavity;   Stage I Mucoepidermoid Carcinoma of the Oral Cavity;   Stage I Squamous Cell Carcinoma of the Hypopharynx;   Stage I Squamous Cell Carcinoma of the Larynx;   Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage I Verrucous Carcinoma of the Larynx;   Stage I Verrucous Carcinoma of the Oral Cavity;   Stage II Adenoid Cystic Carcinoma of the Oral Cavity;   Stage II Mucoepidermoid Carcinoma of the Oral Cavity;   Stage II Squamous Cell Carcinoma of the Hypopharynx;   Stage II Squamous Cell Carcinoma of the Larynx;   Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage II Verrucous Carcinoma of the Larynx;   Stage II Verrucous Carcinoma of the Oral Cavity;   Stage III Adenoid Cystic Carcinoma of the Oral Cavity;   Stage III Mucoepidermoid Carcinoma of the Oral Cavity;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Verrucous Carcinoma of the Larynx;   Stage III Verrucous Carcinoma of the Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IVA Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IVA Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVA Verrucous Carcinoma of the Oral Cavity;   Stage IVB Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IVB Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVB Verrucous Carcinoma of the Larynx;   Stage IVB Verrucous Carcinoma of the Oral Cavity;   Stage IVC Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IVC Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IVC Squamous Cell Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVC Verrucous Carcinoma of the Larynx;   Stage IVC Verrucous Carcinoma of the Oral Cavity;   Tongue Cancer
  Interventions:   Procedure: transoral robotic surgery;   Procedure: quality of life assessment
  Sponsor:   Enver Ozer
  Recruiting
• Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

  NCT03602079

  Conditions:   HER2-positive Breast Cancer;   HER2 Gene Mutation;   HER-2 Gene Amplification;   HER2 Positive Gastric Cancer;   Salivary Gland Cancer;   Salivary Gland Tumor;   Salivary Gland Carcinoma;   Salivary Gland Neoplasms;   Lung Cancer;   Colo-rectal Cancer;   Rare Diseases;   Solid Tumor;   Recurrent Gastric Cancer;   Recurrent Colon Cancer;   Recurrent Breast Cancer;   Head and Neck Cancer;   Head and Neck Carcinoma;   Bladder Cancer;   Cervical Cancer;   Liver Cancer;   Bile Duct Cancer;   Urologic Cancer;   Pancreatic Cancer;   Prostate Cancer;   Recurrent Prostate Cancer;   Rectal Cancer;   Recurrent Ovarian Carcinoma;   Recurrent Renal Cell Cancer;   Rectal Cancer Stage II;   Rectal Cancer Stage I;   Rectal Cancer Stage III;   Skin Cancer;   Mouth Cancer;   Lip Cancer Stage I;   Tongue Cancer;   Breast Neoplasm Malignant Primary;   Larynx Cancer;   Tonsil Cancer;   Palate Cancer;   Mucoepidermoid Carcinoma;   Primary Peritoneal Carcinoma;   Mucinous Adenocarcinoma Gastric;   Mucinous Breast Cancer Recurrent;   Cholangiocarcinoma
  Intervention:   Drug: A166
  Sponsor:   Klus Pharma Inc.
  Recruiting
• Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

  NCT00898638

  Condition:   Head and Neck Cancer
  Interventions:   Other: biologic sample preservation procedure;   Other: medical chart review
  Sponsors:   Vanderbilt University Medical Center;   National Cancer Institute (NCI)
  Recruiting